In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

GSK gains transdermal vaccines from Intercell

Executive Summary

Intercell AG (infectious disease vaccines) has licensed GlaxoSmithKline Biologicals SA rights to its transdermal patch vaccines for traveler's diarrhea (TD) and pandemic flu. GSK also received a license to use Intercell's patch technology for the Big Pharma's marketed vaccines in multiple indications.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
    • Vaccines
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Co-Marketing
    • Includes Equity
    • Includes Royalty or Profit Split Information

Related Companies

Advertisement
UsernamePublicRestriction

Register